Svens Henkuzens, director of the State Agency of Medicines in Latvia discusses the key role of the organization in the country and the objectives he has set to further improve the access to innovative treatments for Latvian patients.
Could you introduce the State Agency of Medicines and its mandate?
"We are committed to reducing national barriers and complexities to launching products and to making our regulatory processes as user friendly as possible without cutting corners or becoming a ‘light touch’ regulator."
